SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-SA -
SEC Accession No. 0001213900-22-060310
Filing Date
2022-09-30
Accepted
2022-09-29 19:15:22
Documents
6
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 SEMIANNUAL REPORT PURSUANT TO REGULATION A ea166462-1sa_emeraldhealth.htm 1-SA 257969
2 CONSULTING AGREEMENT DATED JULY 23, 2022 BETWEEN THE COMPANY AND CATAPULT LIFE S ea166462ex6-18_emeraldhealth.htm EX1SA-6 MAT CTRCT 34569
3 CONSULTING AGREEMENT DATED SEPTEMBER 1, 2022 BETWEEN THE COMPANY AND KRANZ & ASS ea166462ex6-19_emeraldhealth.htm EX1SA-6 MAT CTRCT 85266
4 LEASE AGREEMENT DATED SEPTEMBER 1, 2022 BETWEEN THE COMPANY AND REGUS MANAGEMENT ea166462ex6-20_emeraldhealth.htm EX1SA-6 MAT CTRCT 1243
5 GRAPHIC ex6-20_001.jpg GRAPHIC 419114
6 GRAPHIC ex6-20_002.jpg GRAPHIC 100188
  Complete submission text file 0001213900-22-060310.txt   1095487
Mailing Address 5910 PACIFIC CENTER BLVD SUITE 320, SAN DIEGO CA 92121
Business Address 5910 PACIFIC CENTER BLVD SUITE 320, SAN DIEGO CA 92121 (858) 352-0622
Emerald Health Pharmaceuticals Inc. (Filer) CIK: 0001700800 (see all company filings)

IRS No.: 820669961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 1-SA | Act: 33 | File No.: 24R-00152 | Film No.: 221281809
SIC: 2834 Pharmaceutical Preparations